Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 2000

View Archived Issues

Vivus signs Muse marketing agreement with Paladin for Canada

Company Profile: Myogen

Synsorb updates product developments at BIO-Europe

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Preclinical data show NO-aspirin efficacy in preventing vein graft failure

Patient enrollment and initial treatment completed in PRESTO trial

Milestone reached in Aventis/PPD Discovery new drug development alliance

AxyS Pharmaceuticals reports third quarter progress and product update

BioNumerik and Grelan create new company focused on anticancer therapies

Introgen's gene therapy shows significant proapoptotic activity in preclinical studies

Significant activity seen for squalamine in phase II lung cancer trial

MGI Pharma and MethylGene begin phase II evaluation of MG-98 in head and neck cancer

Company Profile: Intercell

Immunosuppressive profile of FTY-720 further defined in preclinical studies

Heparan sulfate useful for inducing dendritic cell maturation for mounting a primary immune response

Enhanced antifungal activity of FK-463-amphotericin B combination

In vitro antifungal activity of NND-502 highlighted at Nagasaki meeting

Novel steroidal aromatase inhibitor TZA-2237 tested in dog models of BPH

FKBP Ligands: Novel Strategies for the Treatment of Neurodegenerative Disorders

Servier compares in vitro/in vivo antitumor activity of new olivacines to doxorubicin and VP-16

Webcasts from AHA Scientific Sessions now available

RTI and NIDA identify first potent, selective NET ligand from 3-phenyltropane series

Novel pharmaceutical compositions prepared for rosiglitazone

Modulators of metabotropic glutamate receptors disclosed by Roche

R&D at Sanofi-Synthelabo leads to identification of potent PDE5 inhibitors

Novel cyclic tyrosine kinase inhibitors reported by BMS scientists

Novel class of H3 antagonists identified through Novo Nordisk/Boehringer Ingelheim collaboration

Roche's new antiinflammatory agents inhibit alpha4 integrin binding

New gastric antisecretory agents patented by Byk Gulden

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...